Pfizer's $7.7B cost-savings plan is boosting margins and EPS, offsetting COVID revenue declines and patent cliff concerns. Core business is growing 12% ex-COVID, with strength in oncology, vaccines, and internal medicine, plus a robust R&D pipeline. Major patent expirations threaten $15B+ in annual revenue by 2028, but Pfizer is aggressively pursuing pipeline and acquisition strategies.

CHICAGO , July 25, 2025 /PRNewswire/ -- Kellanova (NYSE: K) today announced that its Board of Directors declared a dividend of $0.58 per share on the common stock of Kellanova, payable on September 15, 2025, to shareowners of record at the close of business on is September 2, 2025. The ex-dividend date is September 2, 2025.

YBIT offers high income via call writing on Bitcoin exposure, but the usual caveat exists with capped upside potential if Bitcoin rallies strongly. We covered BTCI recently, and we made several comparisons between the two, where BTCI looks like the stronger fund. YBIT's monthly distributions are attractive for income-focused investors, but they can be quite volatile, similar to the underlying asset.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Intel Corporation's turnaround hinges on delivering a cutting-edge node, specifically ramping Intel 18A at scale, to regain competitiveness with TSMC and Samsung. INTC financials remain weak: gross margins dropped, debt exceeds $50 billion, and the foundry business is losing over $10 billion annually. New management is focused on disciplined investment, right-sizing operations, and leveraging both internal and external foundry partnerships to drive future growth.

Financial Institutions, Inc. (NASDAQ:FISI ) Q2 2025 Earnings Conference Call July 25, 2025 8:30 AM ET Company Participants Kate Croft - Director of Investor & External Relations Martin K. Birmingham - President, CEO & Director William Jack Plants - Executive VP, CFO & Treasurer Conference Call Participants Damon Paul DelMonte - Keefe, Bruyette, & Woods, Inc., Research Division Operator Hello, everyone, and thank you for joining the Financial Institutions, Inc. Second Quarter 2025 Earnings Call.

Equinor posts $955 million impairment on U.S. wind projects, citing regulatory rollbacks, tariffs and lost tax credits.

STX eyes strong Q4 gains as AI-driven cloud growth and Mozaic drive mass storage demand and margin expansion.

CMS may post Q2 earnings growth as rate hikes and renewables earnings offset storm-related and reliability upgrade-related expenses.

Here is how National Vision (EYE) and Nestle SA (NSRGY) have performed compared to their sector so far this year.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here is how ANIXA BIOSCIENCES INC (ANIX) and Mind Medicine (MindMed) Inc. (MNMD) have performed compared to their sector so far this year.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.